Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management

BACKGROUND: Immune checkpoint inhibitors are successfully introduced as anticancer treatment. However, they may induce severe immune-related adverse events (irAEs). One of the most frequent irAEs is diarrhoea. The main objective of this study was to analyse symptoms (ie, grade of diarrhoea), endosco...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ESMO Open
Päätekijät: Geukes Foppen, Marnix H, Rozeman, Elisa A, van Wilpe, Sandra, Postma, Cindy, Snaebjornsson, Petur, van Thienen, Johannes V, van Leerdam, Monique E, van den Heuvel, Michel, Blank, Christian U, van Dieren, Jolanda, Haanen, John B A G
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2018
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5786923/
https://ncbi.nlm.nih.gov/pubmed/29387476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000278
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia